Trial Profile
Evaluation of efficacy and tolerance of sildenafil "on demand" in Raynaud's phenomenon [Evaluation de l'efficacité et de la tolérance du sildénafil "à la demande" dans le phénomène de Raynaud]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Raynaud's disease
- Focus Therapeutic Use
- Acronyms PROFIL
- 30 Oct 2018 Results published in the Annals of Internal Medicine
- 30 Nov 2017 New trial record